First report of CTX-M-14 -producing clinical isolates of Salmonella serovar Typhimurium from Egypt

Journal of Infection in Developing Countries

Volumn 4, Issue 1, 2010, Pages 058-060

  AbdelGhani, Sameh M M ^a,b,c   Moland, Ellen Smith ^a   Black, Jennifer A ^a   Hanson, Nancy D ^a   Goering, Richard V ^a   Thomson, Kenneth S ^a   Amine, Magdy A ^b   Saafan, Amal E ^c   Helal, S ^d   Gaafar, Maha ^d   Younan, Mariam ^d  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CAIRO UNIVERSITY   (Egypt)

^c Beni Suef University   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M 14; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; NITROCEFIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA-LACTAMASE CTX-M-14;

AMINO ACID SEQUENCE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; EGYPT; ENZYME ISOLATION; ESCHERICHIA COLI; HUMAN; ISOELECTRIC FOCUSING; KLEBSIELLA; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA TYPHIMURIUM; SEROTYPE; BIOSYNTHESIS; CHILD; DRUG EFFECT; ENZYMOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; SALMONELLOSIS;

SALMONELLA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EGYPT; HUMANS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 76149091884     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.386     Document Type: Letter

References (7)

1. Glynn MK et al. (1998) Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States N Engl J Med 338: 1333-8.
2. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14.
3. Hammami A et al. (1991)Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis 10: 641-6.
4. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Disc Tests; Approved Standard - Ninth Edition M2-A9. 2006, Clinical and Laboratory Standards Institute: Wayne, PA.
5. Goering V (2004) Pulsed Field Gel Electrophoresis. In Molecular Microbiology: Diagnostic Principles and Practice., D.H.P. , F.C. Tenover, J. Versalovic, Y. Tank, B. Unger, D. Relman and T.J. White (eds.), , Editor, ASM Press, : Washington, D.C. Chapter 15, . p. 185-196.
6. Moland ES et al. (2006) Prevalence of Newer b-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002. J Clin Microbiol 44: p. 3318-24.
7. Hanson ND et al. (2002) Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 beta-lactamases. J Antimicrob Chemother 49: 1011-4.